Pharvaris N.V. PHVS
Set alert
33.53 USD 0.00 0.00%
At close
33.53 0.00 0.00%
Pre-market · Nov 2, 8:53 AM ET
33.10 Day range 33.94
21.02 52-week range 43.25
- YTD
- +20.83%
- 1 year
- +50.76%
- Open
- 33.48
- Prev close
- 33.53
- Mkt cap
- 2.35B
- Vol
- 1.48M
- Avg vol
- 802.06K
- EPS
- -3.06
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 33.10
- High
- 33.94
- Forward P/E
- -10.97
- Beta
- -2.46
- Short ratio
- 3.40
- Inst. own
- 93.42%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 33.72
- 200-d avg
- 30.96
- 1y target
- 57.52
3M chart
Events in this range
- Aug 12, 2026Earnings: -0.81; estimate -0.7467; surprise -8.48%
- Sep 9, 2026Rating: RBC Capital · Outperform → Outperform
- Sep 9, 2026Rating: Wells Fargo · Overweight → Overweight
- Sep 9, 2026Rating: Leerink Partners · Outperform → Outperform
- Sep 9, 2026Rating: Morgan Stanley · Overweight → Overweight
- Sep 10, 2026Rating: Guggenheim · Buy → Buy
- Oct 23, 2026Rating: B of A Securities · Neutral → Buy
Signals (20)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| RSI: Oversold | Oct 15, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 5, 2026 | 4 weeks ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 18, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
Financial health
Altman Z-Score
41.60 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -8.0×
FY 2017 5y median -8.0× FY 2025
P/S 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 5.2×
FY 2017 5y median 2.5× FY 2025
P/FCF -10.2×
FY 2017 5y median -8.6× FY 2025
EV/EBITDA -6.4×
FY 2017 5y median -5.0× FY 2025
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -9.8%
FY 2017 5y median -11.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -64.8%
FY 2017 5y median -50.1% FY 2025
ROIC -62.4%
FY 2017 5y median -54.2% FY 2025
ROA -58.3%
FY 2017 5y median -45.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -16.6%
FY 2017 FY 2025
EPS (diluted) -19.8%
FY 2017 FY 2025
Free Cash Flow -13.7%
FY 2017 FY 2025
Financial Health
Current Ratio 10.1×
FY 2017 5y median 12.6× FY 2025
Quick Ratio 10.1×
FY 2017 5y median 12.6× FY 2025
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 1.7×
FY 2017 5y median 1.9× FY 2025
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31